Optomed webinar on December 9, 2021
AI in eye screenings
Optomed warmly welcomes you to join the webinar on how to improve access to diabetic retinopathy screening with AI and handheld fundus cameras.
The webinar is free of charge and our honored key speaker of the event, Paolo S. Silva, MD, Assistant Chief of Telemedicine presents the benefits of using Artificial Intelligence (AI) in diabetic retinopathy screening.
In this webinar also the SELENA+ AI algorithm used in the Singapore national diabetic retinopathy screening program will be presented.
Save your place to the webinar and register here: https://videopalvelin.fi/optomed-webinar-registration-2021/
Paolo S. Silva, MD
Assistant Chief of Telemedicine, Beetham Eye Institute, Joslin Diabetes Center, Harvard Medical School
Dr. Paolo Silva is staff ophthalmologist and chief of telemedicine at the Beetham Eye Institute of the Joslin Diabetes Center. He is Assistant Professor of Ophthalmology at Harvard Medical School. His primary expertise lies in the fields of ocular telehealth for diabetic retinopathy, ultrawide field (UWF) retinal imaging and electronic medical record review. Dr. Silva has contributed 79 scientific publications with 26 original articles (17 as either first or last author), 16 study group publications, 25 review articles, 2 clinical guidelines and 9 book chapters. His work and efforts have been recognized with 20 national and international awards.
Petri Huhtinen, PhD
Clinical Director, Optomed
Petri has been working with preventive healthcare for the whole Millennium, which has made him a big fan of screening. He likes combining high-tech with human-touch to improve healthcare in general.
Petri manages Optomed’s clinical study portfolio making sure that clinical aspects remain in the core of company’s strategy. He also works closely with Optomed’s AI-partner network to ensure that Optomed’s customers have access to the best AI-solutions available. Petri holds PhD in in vitro diagnostics, MSc in biochemistry and BBA in Information systems science.
Executive, Business Development, EyRIS
Ryan works in the Business Development Team at one of the most innovative companies in Asia, EyRIS. His team has pioneered new business practices and developed new implementation techniques for Deep Learning Artificial Intelligence systems in both local and international markets. Over the course of his career in EyRIS, Ryan has overseen the deployment of SELENA+ in various regions namely Asia, Europe and Latin America. Today, he works with multiple customers, guiding them on their efforts to adopt Artificial Intelligence technology seamlessly and how they can benefit their patients more than ever before.
The event will be hosted by Laura Piila, Vice President Devices and Niina Huikuri, Vice President, Marketing from Optomed
Retinopathy Screening Closer for All: Integrating Poinf of Care Artificial Intelligence
Paolo S. Silva, MD, Assistant Chief of Telemedicine, Beetham Eye Institute, Joslin Diabetes Center, Harvard Medical School
AI in Eye Screenings – Why should we care?
Petri Huhtinen, Clinical Director, Optomed
SELENA+: Artificial Intelligence as a diagnostic tool
Ryan Tan, Executive, Business Development, EyRIS